That's a good suggestion. We're going to start the opiate study next Tuesday. Later, after this discussion, we're also going to talk about the work plan for pharmacare. There's been a suggestion that we might want to have fewer meetings, and we're going to talk about that.
Also, our travel has been denied. I got a notice as well saying that all travel is denied for all committees from now until well into 2017, so I don't think we can count on going across the street, much less to the places we were thinking to go. The analysts have come up with some alternative witnesses we might bring in to give us the same information, or part of it, that we might get by going to the places. We're going to talk about that work plan in a minute.